Cercar

28/10/2025 Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial
Laudani, C, Ortega-Paz, L, Sionis, A, Calés, PV, Arevalos, V, Riba, RA, Morr, C, De Diego, O, Ortega, E, Dantas, AP, Angiolillo, D, Sabate, M, Ortiz-Pérez, JT, Brugaletta, S. Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 86(17)DOI:. PMID:. IF:22.300(Q1/1D).
01/02/2026 Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR)
Mingot-Castellano, ME, Pardos-Gea, J, Rico, AM, Alcalde-Mellado, P, Salvadores-Alvares, V, Jimenes, AJ, Hirnyk, MC, Gutierrez, AB, Bastida, JM, Alén, J, Candel, FG, Penella, DT, Quintana, AM, Navarro, GAM, Palmer, ER, Expósito, MC, Correa, SA, Miñana, LT, Garcia, JAR, Alvarez-Roman, MT, Garcia, RL, Gonzalez, RR, Antoran, JMM, Escobar, NA, Culebras, RA, Badás, MPM, Antonio, SM, Barrientos, MU, Mosteirin, NF, Sanchez, MP, Herrero, SV, Santiago, CC, Miranda, ISC, Mañas, MAP, Fernandez, IV, Izquierdo, CP, Lopez, SC, Vera, PM. Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR). HAEMATOLOGICA. 2026; 111(2)DOI:10.3324/haematol.2025.288480. PMID:40820842. IF:10.100(Q1/2D).
01/02/2026 Antithrombotics drugs in Gastrointestinal Endoscopy. Position Statment of the Catalan Society of Gastroenterology
Pons, FR, Vilalta, N, Ibáñez-Sanz, G, Quintana-Carbó, S, Calvo, A, Uchima, H, García-Iglesias, P, Romero-Mascarell, C, Vallès, E, Alvarez, MA. Antithrombotics drugs in Gastrointestinal Endoscopy. Position Statment of the Catalan Society of Gastroenterology. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502536. PMID:40803483. IF:1.900(Q3/7D).
01/01/2026 A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity
Mulet, M, Osuna-Gómez, L, Martínez-España, L, Artesero, I, Duch-Llorach, P, Vera-Artázcoz, P, Torrens-Sonet, M, Rodríguez-Farré, N, Vilalta, N, Abril-Gamboa, A, Seres, M, Canto, E, Ortiz, MA, López-Contreras, J, Vidal, S. A distinctive immunophenotypic signature in thrombocytopenic septic patients: platelet and neutrophil dysregulations as key contributors to disease severity. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2026; 24(1)DOI:10.1016/j.jtha.2025.09.006. PMID:41038278. IF:5.000(Q1/2D).